No Detail Found!

Distribution of Blood Groups among Patients with Cardiac Myxoma

Author(s)
Mohammad Naderan Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences,Tehran,Iran
Saeed Shoar Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences,Tehran,Iran
Abstract
BACKGROUND: Atrial myxoma is the most common type of primary cardiac tumor. The number of studies examining the possible role of blood groups in cardiovascular diseases is increasing. Our aim was to demonstrate the distribution of ABO and Rh blood groups in a large population of patients with atrial myxoma in Iran. METHODS: In a case-control study design, 35,192 patients undergoing cardiac surgery in a tertiary heart care center in Iran were retrospectively reviewed. Demographic and clinical characteristics of patients with histologically confirmed diagnosis of cardiac myxoma were recorded. Control group consisted of age, gender and year of surgery matched 468 non-cardiac myxoma patients. myxoma, 64 patients (54.7%) were female. Blood group A and O were the most frequent blood types (42.7% and 30.8%, respectively) as well as Rh+ group (82.1%) in the cardiac myxoma group, and blood group O and A were the most frequent blood types (37.8% and 32.8%, respectively) as well as Rh+ group (87.8%) in the control group, although the differences were not statistically significant (p>0.05). There was no significant difference between different ABO blood groups and Rh status for tumor size, family history, recurrence, and mortality rate (p>0.05). CONCLUSION: Blood group A and O and Rh+ status are equally prevalent in patients with and without cardiac myxoma. Whether blood groups have an effect on mortality of patients with cardiac myxoma remains to be seen.
Publication Details
Page(s) 83-86
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 5, Issue: 3, Year: 2015

Request the full text from PASTIC

Keywords
Prevalence, Prevalence, Cardiac myxoma, Blood Group, Rh factor
References
Am J Cardiol .1996 .. , 77(1) : 107.
Goldberg HP,Glenn F,Dotter CT,Steinberg I. .1952 .Myxoma of the left atrium; diagnosis made during life with operative and post-mortem findings. Circulation, 6(5) : 762-7.
.2006 .Atrial myxomas: pathologic types, tumor location, and presenting symptoms. J Card Surg, 21(4) : 435-40.
Gaszewska-Zurek E,Zurek P,Wilczynski M,Krzych L,Bachowski R,Jasinski M .2011 .Cardiac myxoma - clinical presentation and long-term post-operative follow-up. Kardiol Pol, 69(4) : 329-34.
Aggarwal SK,Barik R,Sarma TC,Iyer VR,Sai V,Mishra J .2007 .Clinical presentation and investigation findings in cardiac myxomas: new insights from the developing world. Am Heart J, 154(6) : 1102-7.
Holley DG,Martin GR,Brenner JI,Fyfe DA,Huhta JC,Kleinman CS .1995 .Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports. J Am Coll Cardiol, 26(2) : 516-20.
Peters PJ,Reinhardt S. .2006 .The echocardiographic evaluation of intracardiac masses: a review. J Am Soc Echocardiogr, 19(2) : 230-40.
Pucci A,Gagliardotto P,Zanini C,Pansini S,di Summa M .2000 .Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J, 140(1) : 134-8.
Strecker T,Rosch J,Weyand M,Agaimy A .2012 .Primary and metastatic cardiac tumors: imaging characteristics, surgical treatment, and histopathological spectrum: a 10-year-experience at a German heart center. Cardiovasc Pathol, 21(5) : 436-43.
Amirzadegan A,Salarifar M,Sadeghian S,Davoodi G,Darabian C,Goodarzynejad H C .2006 .Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol, 110(2) : 256-8.
Anvari MS,Boroumand MA,Shoar S,Naderan M,Bina P .2013 .Ascending aorta aneurysm and blood group A among Iranian patients. Thromb Res, 131(2) : e51-3.
Mahmoodi BK,Nijsten M,Wijsman J,Matthews AG .2012 .ABO-blood groups and risk of abdominal aortic aneurysm and peripheral obstructive artery disease: two sides of the same coin. Thromb Res, 129(1) : 89-90.
Lubs ML,Nora JJ,Lubs HA .1972 .Blood-groups and congenital heart-disease. Lancet, 2(7781) : 825-6.
Odegard KC,Laussen PC,Zurakowski D,Hornykewycz SJ,Laussen JC,Hansen DD .2008 .Distribution of ABO phenotypes in patients with congenital cardiac defects. Cardiol Young, 18(3) : 307-10.
Wu O,Bayoumi N,Vickers MA,Clark P. .2008 .ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost, 6(1) : 62-9.
Lev M,Okada R,Kerstein MD,Paiva R,Rimoldi HJ .1967 .Blood groups and congenital heart disease. Dis Chest, 52(5) : 616-20.
Yoon DH,Roberts W. Sex .2002 .distribution in cardiac myxomas. Am J Cardiol, 90(5) : 563-5.
Stern R .1996 .Cardiac myxomas. N Engl J Med, 334(21) : 1408.
Pinede L,Duhaut P,Loire R. .2001 .Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore), 80(3) : 159-72.
0

Citations

0

Downloads

9

Views